Sim, Edmund Koon Yin 沈觀賢
Manager/adviser/other
Organisation | Position | From | Until | Total Return |
CAGR total return |
CAGR relative return |
||
---|---|---|---|---|---|---|---|---|
1 | * | HighTide Therapeutics, Inc. | CFOChief Financial Officer | 2022-12-01 | -87.72% | -96.00% | -96.56% | |
Average | -96.00% | -96.56% |
SFC roles
Organisation | Position | From | Until | ||
---|---|---|---|---|---|
1 | BOCI ASIA LIMITED | RepRepresentative | 2004-03-01 | ||
2 | CHINA MERCHANTS SECURITIES (HK) CO., LIMITED | RepRepresentative | 2012-11-13 | 2013-12-04 | |
Resp OffResponsible Officer | 2013-12-04 | 2018-07-20 | |||
3 | Citigroup Global Markets Asia Limited | RepRepresentative | 2004-03-15 | 2008-04-15 | |
4 | CITIGROUP GLOBAL MARKETS HONG KONG FUTURES AND SECURITIES LIMITED | RepRepresentative | 2004-03-15 | 2008-04-15 | |
5 | GOLDMAN SACHS (ASIA) L.L.C. | RepRepresentative | 2008-06-04 | 2010-03-13 | |
6 | Merrill Lynch (Asia Pacific) Limited | RepRepresentative | 2010-05-18 | 2012-07-12 | |
7 | Merrill Lynch Far East Limited | RepRepresentative | 2010-05-18 | 2012-07-12 |
Some data are hidden to fit your display. Rotate?
Total returns are measured from the latest of the start date, the appointment date and 3-Jan-1994 until the earliest of the end date, the resignation/removal date and the last trading date. CAGR is the annualised return and is not shown for periods under 180 days. Relative returns are to the Tracker Fund of HK (2800), starting from the latest of 12-Nov-1999, the appointment date and the chosen start date.
* = is or was HK primary-listed
Sign up for our free newsletter
Recommend Webb-site to a friend
Copyright & disclaimer, Privacy policy